[{"NetIncomeLoss_1_Q1_USD":-8328000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":7377000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":11542000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":48.69,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":405000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":16235000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":608000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":56373000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-17445000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":1479000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":619000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":8000.0,"AssetsCurrent_0_Q1_USD":445942000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4344000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":833000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":87417000.0,"UnrecognizedTaxBenefits_0_Q1_USD":675000.0,"CommonStockSharesIssued_0_Q1_shares":20142000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":349563000.0,"Assets_0_Q1_USD":481012000.0,"ShareBasedCompensation_1_Q1_USD":4883000.0,"DepreciationAndAmortization_1_Q1_USD":871000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":43.39,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-439000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":-104000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":48.69,"EarningsPerShareBasic_1_Q1_USD":-0.41,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":20093000.0,"AssetsFairValueDisclosure_0_Q1_USD":394380000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-2498000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":677000.0,"AccountsReceivableNetCurrent_0_Q1_USD":31743000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-3294000.0,"CommonStockValue_0_Q1_USD":201000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":18462000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":7775000.0,"LiabilityForUncertainTaxPositionsNoncurrent_0_Q1_USD":675000.0,"CostsAndExpenses_1_Q1_USD":44042000.0,"AssetRetirementObligationsNoncurrent_0_Q1_USD":299000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q1_USD":-534000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-8767000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":575000.0,"OtherAssetsNoncurrent_0_Q1_USD":92000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":55095000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3520000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":332145000.0,"Liabilities_0_Q1_USD":29017000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":299000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":69.62,"DeferredIncomeTaxAssetsNet_0_Q1_USD":345000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":104674000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":3789000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-439000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":798000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-11622000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":534000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":4883000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-14890000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":20093000.0,"LiabilitiesCurrent_0_Q1_USD":23044000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.41,"AccountsPayableCurrent_0_Q1_USD":6305000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":28003000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":833000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":890000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":16235000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":55703000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":33000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":62000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q1_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":16206000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":7788000.0,"NonoperatingIncomeExpense_1_Q1_USD":677000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":36665000.0,"CommonStockSharesOutstanding_0_Q1_shares":20142000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-32036000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1307000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":31743000.0,"OperatingIncomeLoss_1_Q1_USD":-12299000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":331101000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":43.45,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":25.25,"LiabilitiesAndStockholdersEquity_0_Q1_USD":481012000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2235000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":4883000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":8251000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":59000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":1907000.0,"ProfitLoss_1_Q1_USD":-8328000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":974000.0,"StockholdersEquity_0_Q1_USD":451995000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":188000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":348773000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-431000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":3789000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2234000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":119244000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5197000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":504000.0,"Ticker":"ENTA","CIK":"1177648","name":"ENANTA PHARMACEUTICALS INC","OfficialName":"Enanta Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1492537180.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210209"}]